Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Live Attenuated Polio Vaccine Global Market Report 2025
Download Free Sample Buy Now
Global Live Attenuated Polio Vaccine Market Report 2025

Report Price : $4490.00

Pages : 200

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Live Attenuated Polio Vaccine Global Market Report 2025

By Vaccine Type (Monovalent, Bivalent, Trivalent), By Administration Route (Oral Administration, Intramuscular Injection, Subcutaneous Injection), By Age Group (Infants (0-1 years), Children (1-5 years), Adults (Above 5 years)), By End-User (Hospitals, Clinics, Public Health Agencies, Other End-Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Live Attenuated Polio Vaccine Market Overview

• Live Attenuated Polio Vaccine market size has reached to $1.85 billion in 2024

• Expected to grow to $2.65 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%

• Growth Driver: Expansion Of Immunization Programs Fueling The Growth Of The Market Due To Enhanced Vaccine Accessibility And Disease Prevention

• Market Trend: Regulatory Approvals For Next-Generation Live Attenuated Polio Vaccines

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Live Attenuated Polio Vaccine Market?

The live attenuated polio vaccine (LAPV) is an oral polio vaccine (OPV) that contains a weakened form of the poliovirus that stimulates a strong immune response without causing disease in healthy individuals. It mimics natural infection, offering long-lasting immunity and helping prevent virus transmission within communities.

The main types of vaccines in live attenuated polio vaccine are monovalent, bivalent, and trivalent. A monovalent oral polio vaccine (mOPV) is designed to protect against only one specific type of poliovirus, either type 1, type 2, or type 3. It is administered through oral administration, intramuscular injection, or subcutaneous injection for various age groups, including infants (0-1 years), children (1-5 years), and adults (above 5 years). It caters to various end users, including hospitals, clinics, public health agencies, and other end users.

Live Attenuated Polio Vaccine Market Size and growth rate 2025 to 2029: Graph

What Is The Live Attenuated Polio Vaccine Market Size 2025 And Growth Rate?

The live attenuated polio vaccine market size has grown strongly in recent years. It will grow from $1.85 billion in 2024 to $1.98 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to mass immunization campaigns, the emergence of vaccine-derived poliovirus concerns, government immunization programs, public awareness and education, and vaccine accessibility and affordability.

What Is The Live Attenuated Polio Vaccine Market Growth Forecast?

The live attenuated polio vaccine market size is expected to see strong growth in the next few years. It will grow to $2.65 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to improved vaccine stability and shelf life, a resurgence of polio cases in conflict zones, donor fatigue in eradication efforts, expansion of routine immunization programs, and increased R&D for safer live attenuated vaccine strains. Major trends in the forecast period include the emergence of vaccine-derived poliovirus, the development of oral polio vaccine, technological advancements in vaccine formulations, the integration of digital technologies, and public-private partnerships.

The forecast of 7.6% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper U.S. public health efforts by increasing the cost of polio vaccine production materials and cold chain packaging imported from Belgium and Indonesia, thereby jeopardizing vaccination programs and elevating immunization campaign costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Live Attenuated Polio Vaccine Market Segmented?

1) By Vaccine Type: Monovalent, Bivalent, Trivalent

2) By Administration Route: Oral Administration, Intramuscular Injection, Subcutaneous Injection

3) By Age Group: Infants (0-1 years), Children (1-5 years), Adults (Above 5 years)

4) By End-User: Hospitals, Clinics, Public Health Agencies, Other End-Users

Subsegments:

1) Monovalent: mOPV1 For Serotype 1

2) Bivalent: Type 1, Type 3

3) Trivalent: Poliovirus Type 1, Poliovirus Type 2, Poliovirus Type 3

What Is Driving The Live Attenuated Polio Vaccine Market? Expansion Of Immunization Programs Fueling The Growth Of The Market Due To Enhanced Vaccine Accessibility And Disease Prevention

The expansion of immunization programs is expected to propel the growth of the live attenuated polio vaccine market going forward. Immunization programs refer to organized efforts by governments, health organizations, or other institutions to provide vaccines to populations to prevent the spread of infectious diseases. The expansion of immunization programs is primarily due to increased global awareness of the importance of disease prevention and strong support from governments, international health organizations, and funding bodies. Immunization programs support the live attenuated polio vaccine (LAPV) by ensuring widespread distribution, safe administration, and high coverage to build herd immunity, prevent virus transmission, and aid in global polio eradication. For instance, in October 2023, according to the Centers for Disease Control and Prevention, a US-based national public health agency, between 2021 and 2022, global coverage for the first dose of the diphtheria-tetanus-pertussis (DTP) vaccine rose from 86% to 89%. Therefore, the expansion of immunization programs is driving the growth of the live attenuated polio vaccine industry.

Who Are The Major Players In The Global Live Attenuated Polio Vaccine Market?

Major companies operating in the live attenuated polio vaccine market are Sanofi Pasteur, GlaxoSmithKline plc, LG Chem Ltd., Serum Institute of India Pvt. Ltd., Biological E. Limited, Indian Immunologicals Limited, Sinovac Biotech Ltd., Shenzhen Kangtai Biological Products Co. Ltd., Vabiotech, Emergent BioSolutions Inc., Valneva SE, Bio Farma, PT Bio Farm, Bilthoven Bio, Panacea Biotec, Haffkine Biopharmaceutical, Panacea Biotec Ltd., Zydus Cadila, Liaoning Cheng Da Biotechnology Co.Ltd, Bharat Biotech International Limited

What Are The Key Trends Of The Global Live Attenuated Polio Vaccine Market? Regulatory Approvals For Next-Generation Live Attenuated Polio Vaccines

Major companies operating in the live attenuated polio vaccine market are focusing on obtaining regulatory approvals to ensure their vaccines meet the safety and efficacy standards required by health authorities globally. Regulatory approvals refer to the formal authorization granted by government health agencies or regulatory bodies, allowing a product, such as a vaccine, to be marketed, sold, and used within a specific region or country. For instance, in July 2024, Biological E, an India-based pharmaceutical and biologics company, received approval from the World Health Organization (WHO) for its novel oral polio vaccine type 2 (nOPV2), a next-generation live, attenuated oral vaccine designed to address the challenges associated with traditional oral polio vaccines. This next-generation vaccine is designed to combat circulating vaccine-derived poliovirus type 2 (cVDPV2) outbreaks more effectively than its predecessor. nOPV2 is engineered with enhanced genetic stability, reducing the risk of the vaccine virus reverting to a virulent form, which has been a concern with older vaccines.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Live Attenuated Polio Vaccine Market? SK Bioscience Acquires IDT Biologika To Strengthen Global Vaccine Capabilities

In June 2024, SK bioscience, a South Korea-based vaccine and biotech company, acquired IDT Biologika for approximately $244 million. With this acquisition, SK bioscience aims to strengthen its vaccine development and manufacturing leadership, expanding its capabilities and service offerings to drive global health improvements and align with its vision for operational growth and innovation. IDT Biologika is a Germany-based contract development and manufacturing organization for viral vaccines, including live attenuated virus vaccines.

What Is The Regional Outlook For The Global Live Attenuated Polio Vaccine Market?

North America was the largest region in the live attenuated polio vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Live Attenuated Polio Vaccine Market?

The live attenuated polio vaccine market consists of sales of monovalent oral polio vaccine (mOPV), bivalent oral polio vaccine (bOPV), novel oral polio vaccine, and trivalent oral polio vaccine (tOPV). Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Live Attenuated Polio Vaccine Industry?

The live attenuated polio vaccine market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the live attenuated polio vaccine industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Live Attenuated Polio Vaccine Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $1.98 billion
Revenue Forecast In 2034 $2.65 billion
Growth Rate CAGR of 7.6% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The live attenuated polio vaccine market covered in this report is segmented –
1) By Vaccine Type: Monovalent, Bivalent, Trivalent
2) By Administration Route: Oral Administration, Intramuscular Injection, Subcutaneous Injection
3) By Age Group: Infants (0-1 years), Children (1-5 years), Adults (Above 5 years)
4) By End-User: Hospitals, Clinics, Public Health Agencies, Other End-Users Subsegments:
1) Monovalent: mOPV1 For Serotype 1
2) Bivalent: Type 1, Type 3
3) Trivalent: Poliovirus Type 1, Poliovirus Type 2, Poliovirus Type 3
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Sanofi Pasteur, GlaxoSmithKline plc, LG Chem Ltd., Serum Institute of India Pvt. Ltd., Biological E. Limited, Indian Immunologicals Limited, Sinovac Biotech Ltd., Shenzhen Kangtai Biological Products Co. Ltd., Vabiotech, Emergent BioSolutions Inc., Valneva SE, Bio Farma, PT Bio Farm, Bilthoven Bio, Panacea Biotec, Haffkine Biopharmaceutical, Panacea Biotec Ltd., Zydus Cadila, Liaoning Cheng Da Biotechnology Co.Ltd, Bharat Biotech International Limited
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Live Attenuated Polio Vaccine Market Characteristics

3. Live Attenuated Polio Vaccine Market Trends And Strategies

4. Live Attenuated Polio Vaccine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Live Attenuated Polio Vaccine Growth Analysis And Strategic Analysis Framework

5.1. Global Live Attenuated Polio Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Live Attenuated Polio Vaccine Market Growth Rate Analysis

5.4. Global Live Attenuated Polio Vaccine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Live Attenuated Polio Vaccine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Live Attenuated Polio Vaccine Total Addressable Market (TAM)

6. Live Attenuated Polio Vaccine Market Segmentation

6.1. Global Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Monovalent

Bivalent

Trivalent

6.2. Global Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral Administration

Intramuscular Injection

Subcutaneous Injection

6.3. Global Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Infants (0-1 years)

Children (1-5 years)

Adults (Above 5 years)

6.4. Global Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Clinics

Public Health Agencies

Other End-Users

6.5. Global Live Attenuated Polio Vaccine Market, Sub-Segmentation Of Monovalent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

mOPV1 For Serotype 1

6.6. Global Live Attenuated Polio Vaccine Market, Sub-Segmentation Of Bivalent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Type 1

Type 3

6.7. Global Live Attenuated Polio Vaccine Market, Sub-Segmentation Of Trivalent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Poliovirus Type 1

Poliovirus Type 2

Poliovirus Type 3

7. Live Attenuated Polio Vaccine Market Regional And Country Analysis

7.1. Global Live Attenuated Polio Vaccine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Live Attenuated Polio Vaccine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Live Attenuated Polio Vaccine Market

8.1. Asia-Pacific Live Attenuated Polio Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Live Attenuated Polio Vaccine Market

9.1. China Live Attenuated Polio Vaccine Market Overview

9.2. China Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Live Attenuated Polio Vaccine Market

10.1. India Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Live Attenuated Polio Vaccine Market

11.1. Japan Live Attenuated Polio Vaccine Market Overview

11.2. Japan Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Live Attenuated Polio Vaccine Market

12.1. Australia Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Live Attenuated Polio Vaccine Market

13.1. Indonesia Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Live Attenuated Polio Vaccine Market

14.1. South Korea Live Attenuated Polio Vaccine Market Overview

14.2. South Korea Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Live Attenuated Polio Vaccine Market

15.1. Western Europe Live Attenuated Polio Vaccine Market Overview

15.2. Western Europe Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Live Attenuated Polio Vaccine Market

16.1. UK Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Live Attenuated Polio Vaccine Market

17.1. Germany Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Live Attenuated Polio Vaccine Market

18.1. France Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Live Attenuated Polio Vaccine Market

19.1. Italy Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Live Attenuated Polio Vaccine Market

20.1. Spain Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Live Attenuated Polio Vaccine Market

21.1. Eastern Europe Live Attenuated Polio Vaccine Market Overview

21.2. Eastern Europe Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Live Attenuated Polio Vaccine Market

22.1. Russia Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Live Attenuated Polio Vaccine Market

23.1. North America Live Attenuated Polio Vaccine Market Overview

23.2. North America Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Live Attenuated Polio Vaccine Market

24.1. USA Live Attenuated Polio Vaccine Market Overview

24.2. USA Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Live Attenuated Polio Vaccine Market

25.1. Canada Live Attenuated Polio Vaccine Market Overview

25.2. Canada Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Live Attenuated Polio Vaccine Market

26.1. South America Live Attenuated Polio Vaccine Market Overview

26.2. South America Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Live Attenuated Polio Vaccine Market

27.1. Brazil Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Live Attenuated Polio Vaccine Market

28.1. Middle East Live Attenuated Polio Vaccine Market Overview

28.2. Middle East Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Live Attenuated Polio Vaccine Market

29.1. Africa Live Attenuated Polio Vaccine Market Overview

29.2. Africa Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Live Attenuated Polio Vaccine Market Competitive Landscape And Company Profiles

30.1. Live Attenuated Polio Vaccine Market Competitive Landscape

30.2. Live Attenuated Polio Vaccine Market Company Profiles

30.2.1. Sanofi Pasteur Overview, Products and Services, Strategy and Financial Analysis

30.2.2. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

30.2.3. LG Chem Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Serum Institute of India Pvt. Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Biological E. Limited Overview, Products and Services, Strategy and Financial Analysis

31. Live Attenuated Polio Vaccine Market Other Major And Innovative Companies

31.1. Indian Immunologicals Limited

31.2. Sinovac Biotech Ltd.

31.3. Shenzhen Kangtai Biological Products Co. Ltd.

31.4. Vabiotech

31.5. Emergent BioSolutions Inc.

31.6. Valneva SE

31.7. Bio Farma

31.8. PT Bio Farm

31.9. Bilthoven Bio

31.10. Panacea Biotec

31.11. Haffkine Biopharmaceutical

31.12. Panacea Biotec Ltd.

31.13. Zydus Cadila

31.14. Liaoning Cheng Da Biotechnology Co.Ltd

31.15. Bharat Biotech International Limited

32. Global Live Attenuated Polio Vaccine Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Live Attenuated Polio Vaccine Market

34. Recent Developments In The Live Attenuated Polio Vaccine Market

35. Live Attenuated Polio Vaccine Market High Potential Countries, Segments and Strategies

35.1 Live Attenuated Polio Vaccine Market In 2029 - Countries Offering Most New Opportunities

35.2 Live Attenuated Polio Vaccine Market In 2029 - Segments Offering Most New Opportunities

35.3 Live Attenuated Polio Vaccine Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Live Attenuated Polio Vaccine Market, Sub-Segmentation Of Monovalent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Live Attenuated Polio Vaccine Market, Sub-Segmentation Of Bivalent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Live Attenuated Polio Vaccine Market, Sub-Segmentation Of Trivalent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Live Attenuated Polio Vaccine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Live Attenuated Polio Vaccine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Sanofi Pasteur Financial Performance
  • Table 79: GlaxoSmithKline plc Financial Performance
  • Table 80: LG Chem Ltd. Financial Performance
  • Table 81: Serum Institute of India Pvt. Ltd. Financial Performance
  • Table 82: Biological E. Limited Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Live Attenuated Polio Vaccine Market, Sub-Segmentation Of Monovalent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Live Attenuated Polio Vaccine Market, Sub-Segmentation Of Bivalent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Live Attenuated Polio Vaccine Market, Sub-Segmentation Of Trivalent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Live Attenuated Polio Vaccine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Live Attenuated Polio Vaccine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Sanofi Pasteur Financial Performance
  • Figure 79: GlaxoSmithKline plc Financial Performance
  • Figure 80: LG Chem Ltd. Financial Performance
  • Figure 81: Serum Institute of India Pvt. Ltd. Financial Performance
  • Figure 82: Biological E. Limited Financial Performance

Emerging Trends and Growth Drivers in the Pediatric Dental Market Through 2029

Read More About Emerging Trends and Growth Drivers in the Pediatric Dental Market Through 2029

Competitive and Market Trend Analysis of Pharmaceutical Cold Chain Packaging Industry Through 2029

Read More About Competitive and Market Trend Analysis of Pharmaceutical Cold Chain Packaging Industry Through 2029

Key Market Drivers, Trends, and Forecast for the Global Pharmaceutical Warehousing Industry

Read More About Key Market Drivers, Trends, and Forecast for the Global Pharmaceutical Warehousing Industry

2025 Analysis: Opportunities and Risks in the Evolving Precision Genomic Testing Market

Read More About 2025 Analysis: Opportunities and Risks in the Evolving Precision Genomic Testing Market

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Read More About Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Vaccines Global Market Report 2022 – By Type (Anti-Infective Vaccines, Autoimmunity, Others (Cancer And Others)), By Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant...

View Report

Vaccine Delivery Devices Global Market Report 2025 – By Type Of Device (Needle Free Injection Systems, Oral Delivery Systems, Nasal Delivery Systems, Jet Injectors, Microneedle Patches And Microinjectors), By Route Of Ad...

View Report

Preventive Vaccines Global Market Report 2025 - By Type (Live Or Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Subunit Vaccines, Conjugate Vaccines, DNA Vaccines, Recombinant Vector Vaccines), By Disease Ty...

View Report

Therapeutic BCG Vaccines Global Market Report 2025 – By Type (Therapy BCG, Immune BCG), By Demographics (Pediatrics, Adults), By End Use (Hospitals, Clinics, Other End Users ) – Impact of Tariff and Trade War on Market S...

View Report

Vaccine Adjuvants Global Market Report 2025 – By Product Type (Adjuvant Emulsions, Pathogen Components, Particulate Adjuvants, Combination Adjuvants, Other Product Types), By Route of Application (Human Vaccine Adjuvants...

View Report

Preventive Vaccines Global Market Report 2025 - By Type (Live Or Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Subunit Vaccines, Conjugate Vaccines, DNA Vaccines, Recombinant Vector Vaccines), By Disease Ty...

View Report

Conjugate Vaccine Global Market Report 2025 – By Product Type (Monovalent Conjugate Vaccines, Multivalent Conjugate Vaccine), By Pathogen (Bacterial, Viral), By Disease Indication (Pneumococcal, Influenza, Meningococcal,...

View Report

Inactivated Vaccines Global Market Report 2025 – By Type (Viral Vaccine, Bacterial Vaccine), By Method Of Inactivation (Solvent Detergent, Radiation, pH Concentration, Heat Inactivation, Other Methods Of Inactivation), B...

View Report

Frequently Asked Questions

The live attenuated polio vaccine (LAPV) is an oral polio vaccine (OPV) that contains a weakened form of the poliovirus that stimulates a strong immune response without causing disease in healthy individuals. It mimics natural infection, offering long-lasting immunity and helping prevent virus transmission within communities. For further insights on this market, request a sample here

The market major growth driver - Expansion Of Immunization Programs Fueling The Growth Of The Market Due To Enhanced Vaccine Accessibility And Disease Prevention. For further insights on this market, request a sample here

The live attenuated polio vaccine market size has grown strongly in recent years. It will grow from $1.85 billion in 2024 to $1.98 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to mass immunization campaigns, the emergence of vaccine-derived poliovirus concerns, government immunization programs, public awareness and education, and vaccine accessibility and affordability. The live attenuated polio vaccine market size is expected to see strong growth in the next few years. It will grow to " $2.65 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to improved vaccine stability and shelf life, a resurgence of polio cases in conflict zones, donor fatigue in eradication efforts, expansion of routine immunization programs, and increased R&D for safer live attenuated vaccine strains. Major trends in the forecast period include the emergence of vaccine-derived poliovirus, the development of oral polio vaccine, technological advancements in vaccine formulations, the integration of digital technologies, and public-private partnerships. For further insights on this market, request a sample here

The live attenuated polio vaccinemarket covered in this report is segmented –
1) By Vaccine Type: Monovalent; Bivalent; Trivalent
2) By Administration Route: Oral Administration; Intramuscular Injection; Subcutaneous Injection
3) By Age Group: Infants (0-1 years); Children (1-5 years); Adults (Above 5 years)
4) By End-User: Hospitals; Clinics; Public Health Agencies; Other End-Users Subsegments:
1) Monovalent: mOPV1 For Serotype 1
2) Bivalent: Type 1; Type 3
3) Trivalent: Poliovirus Type 1; Poliovirus Type 2; Poliovirus Type 3 For further insights on this market, request a sample here

North America was the largest region in the live attenuated polio vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the live attenuated polio vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the live attenuated polio vaccine market are Sanofi Pasteur, GlaxoSmithKline plc, LG Chem Ltd., Serum Institute of India Pvt. Ltd., Biological E. Limited, Indian Immunologicals Limited, Sinovac Biotech Ltd., Shenzhen Kangtai Biological Products Co. Ltd., Vabiotech, Emergent BioSolutions Inc., Valneva SE, Bio Farma, PT Bio Farm, Bilthoven Bio, Panacea Biotec, Haffkine Biopharmaceutical, Panacea Biotec Ltd., Zydus Cadila, Liaoning Cheng Da Biotechnology Co.Ltd, Bharat Biotech International Limited . For further insights on this market, request a sample here.

Major trends in this market include Regulatory Approvals For Next-Generation Live Attenuated Polio Vaccines. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Live Attenuated Polio Vaccine Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon